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Abstract 
We  present  a  case  of  an  intramedullary
melanotic schwannoma (IMS) of the thoracic
spinal cord. To our knowledge, this is the sev-
enth  reported  case  of  an  IMS  of  the  central
nervous  system.  Schwannomas  are  benign
nerve  sheath  tumors  of  neural  crest  origin
composed  entirely  of  well  differentiated
Schwann cells that typically occur in peripheral
nerves. Both the intramedullary location and
the melanotic component of the reported lesion
make it exceedingly rare. We will present our
case, theories as to the origin of these tumors,
clues in radiographic identification, and cur-
rent clinical follow-up recommendations. 
Case Report
Presentation and history
The patient is a 62-year-old female with a
several year history of aching in both thighs.
Three months prior to presentation she began
having radicular pain in the thighs. The pain
was  worse  when  standing  and  walking.  She
denied  significant  back  pain.  She  reported
reduced strength in the legs and numbness in
her  legs  to  the  dorsum  of  her  feet,  urinary
urgency, and urinary incontinence. 
Physical examination
Her examination demonstrated mild (4 out
of 5) weakness of the iliopsoas and hamstrings
bilaterally.  Temperature  and  pain  sensation
was reduced below the T12 level. She had mild
difficulty with tandem walking. 
Initial diagnosis and radiography
Magnetic resonance imaging (MRI) of the
thoracic  spine  revealed  a  1.2¥1.0¥1.1  cm
intramedullary mass posterior to the T11 verte-
bral body within the spinal canal (Figures 1-3).
There was spinal cord expansion and edema
above  and  below  the  mass  evidenced  by  T2
hyperintensity.  The  lesion  was  T1  hyperin-
tense and T2 hypointense. 
Operative course
The  patient  underwent  T10-T11  laminec-
tomies.  The  dura  was  thinned  posteriorly
where the lesion presented intradurally. Dark
pigmentation  was  visible  through  the  dura.
The dura was opened in the midline exposing
an intramedullary lesion reminiscent of a cav-
ernous  malformation  (Figure  4).  The  lesion
was carefully resected from the surrounding
cord and sent whole for pathological analysis
(Figure 5). 
Pathology
Hematoxylin  and  eosin  staining  was  per-
formed and demonstrated a heavily pigmented
spindle cell neoplasm suggestive of a melanot-
ic schwannoma (Figure 6). Tumor cells stained
with antibodies to melan-A (Figure 7). MIB-1
labeling index was very low, although difficult
to interpret due to the dark pigmentation of
the tissue (not shown). A collagen IV stain was
positive and a reticulin stain revealed a dense
reticular  pericellular  network  (not  shown)
suggesting the presence of a pericellular base-
ment membrane as typical of well differentiat-
ed Schwann cells. Electron microscopy, in addi-
tion to intracellular late stage melanosomes,
demonstrated  the  presence  of  a  continuous
pericellular  basal  lamina  confirming  the
schwannian  nature  of  the  cells  (Figure  8).
Thus, the diagnosis of intramedullary melanot-
ic schwannoma (IMS) was made. 
Post-operative course
Immediately postoperatively, the patient had
weakness  in  the  proximal  left  leg.  She  had
diminished sensation to light touch and tem-
perature in the right leg. Her strength and sen-
sation in the lower extremities improved over
the following days and the patient was subse-
quently transferred to inpatient rehabilitation.
A post-operative MRI performed three months
after surgery revealed no evidence for residual
or recurrent tumor (Figures 9A and 9B). Since
a  gross  total  resection  was  confirmed  radi-
ographically, we did not recommend any adju-
vant treatment. We recommended close clini-
cal  and  radiographic  observation  with  semi-
annual MRI’s.
Ten months post-operatively the patient had
resolution  of  her  neurogenic  bladder  symp-
toms and was voiding spontaneously. She was
able to walk at least a half block with a walker.
Her neurologic exam revealed diffuse mild cor-
ticospinal weakness in the lower extremities
bilaterally  with  spasticity  in  the  right  lower
extremity. She had bilateral plantar extensor
responses. The patient had sensory deficits in
the  lower  extremities  resulting  in  sensory
ataxia. 
Discussion
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Figure  1.  A)  Sagittal  T1  magnetic  resonance  imaging  without  gadolinium  contrast;
B) Sagittal T2 magnetic resonance imaging.
ABSchwannomas  are  benign  nerve  sheath
tumors, which display advanced Schwann cell
differentiation and are the most common type
of peripheral nerve tumor in adults, prevalent
in  those  30-50  years  old  without  gender
predilection.1 Most extracranial schwannomas
are sporadic rather than associated with neu-
rofibromatosis  type  2.  They  are  often  slow
growing masses that can occur anywhere dis-
tal to the oligodendroglial-Schwann cell myeli-
nation junction.1 The intramedullary location,
as in this case, is rare for schwannomas. 
The melanotic appearance of the reported
intramedullary  schwannoma  is  also  a  rare
entity  involving  cytoplasmic  deposition  of
melanin  from  functional  melanosomes.
Theories  explaining  the  melanin  producing
properties of these cells include neoplastic dif-
ferentiation of neural crest cells into Schwann
cells  with  melanogenetic  properties  and
melanocytic transformation of previously nor-
mal  Schwann  cells.2 These  tumors  typically
occur in the spinal nerves and ganglia. The
presence of psammoma bodies is typical of the
psammomatous variant of melanotic schwan-
noma, a tumor which most frequently occurs
in the autonomic nerves and viscera, including
the intestinal tract and heart. Approximately
50% of patient with psammomatous melanotic
schwannomas are affected by the Carney com-
plex,  an  autosomal  dominant  disorder  with
coexisting morbidities such as cardiac myxo-
mas.3 Carney complex involves skin pigmen-
tary  abnormalities,  myxomas,  endocrine
tumors or overactivity, and schwannomas. The
psammomatous  melanotic  schwannoma
occurs in an estimated 10% of affected individ-
uals affected by the Carney complex.4
IMS is a very rare entity. This is only the 7th
reported case to our knowledge describing this
tumor (Table 1).2,5-9Various explanations for this
tumor’s unusual location in the central nerv-
ous system have been put forth (Table 2).6,8,10-13
MRI is the preferred method of evaluating
lesions of the spine cord. Melanotic lesions will
appear  hyperintense  on  T1weighted  images
A B C
Figure 2. Axial T2 magnetic resonance imaging fast spin echo at A) T11 (cephalad); B) T11 (middle); C) T11 (caudal).
A B
Figure 3. A) Sagittal T1 magnetic resonance imaging with gadolinium contrast; B) axial
T1 magnetic resonance imaging with gadolinium contrast at T11.
Figure 5. Gross specimen.
Figure 6. Hematoxylin and eosin stain. Figure 7. Melan-A stain.
Figure 4. Intra-operative photograph.
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[page 8] [Rare Tumors 2012; 4:e1]and hypointense on T2 weighted images due to
paramagnetic  free  radicals  in  melanin.14 In
contrast,  non-melanotic  tumors  are
hypointense  on  T1  weighted  images  and
hyperintense  on  T2  weighted  images  and
chronic hematomas are hyperintense on both
T1 and T2 weighted images which help to dif-
ferentiate the melanotic from non-melanotic
lesions. However, there can be some difficulty
in  differentiating  subacute  hematomas  from
melanotic  lesions  since  they  share  similar
characteristics  on  MRI.15 This  is  what  most
likely led to the initial radiographic diagnosis
of cavernous malformation in our case.
MRI  characteristics  of  intramedullary
schwannomas  are  fairly  inconsistent.
Administration of gadolinium can cause nodu-
lar enhancement of schwannomas when cystic
components are present, but is mainly useful
in  differentiating  intramedullary  schwanno-
mas from spinal cord edema.12,16 A confident
diagnosis of intramedullary schwannoma can
be made preoperatively when there is continu-
ity of the intramedullary lesion with a contrast
enhancing thickened spinal root.12
Complete  surgical  excision  of
intramedullary  schwannomas  is  considered
curative, effective, and safe. Schwannomas are
normally benign encapsulated tumors. In con-
trast, approximately 10% of melanotic schwan-
nomas  have  been  reported  to  pursue  an
aggressive  clinical  course  with  local  recur-
rence and metastases including seeding of the
subarachnoid space.2,14 The presence of multi-
ple lesions however is not synonymous with
seeding since multiple independent schwan-
nomas  may  occur.  Whenever  possible,  com-
plete resection and careful follow-up should be
practiced  with  any  melanotic  schwannoma
regardless of location. Radiotherapy following
subtotal resection of an intramedullary melan-
otic schwannoma is recommended due to the
tumor’s potential for recurrence and metasta-
sis.17 In our experience, melanotic lesions of
the spinal cord may behave in an unpredictable
fashion. While we do not believe radiotherapy
is necessary when a gross total resection is
possible and postoperative MRI confirms this,
we recommend close MRI follow-up. It is our
usual  practice  to  image  spinal  cord  tumors
annually  following  surgical  resection;  we
shorten this interval to six months, at least ini-
tially, for melanotic tumors of the spinal cord.
Conclusions
MRI is the preferred method for evaluating
lesions of the spine cord. Melanotic lesions will
appear  T1  hyperintense  and  T2  hypointense
due to paramagnetic free radicals in melanin.
In  contrast,  non-melanotic  tumors  are  T1
hypointense and T2 hyperintense. There can
be some difficulty in differentiating early sub-
acute hematomas from melanotic lesions and
this may lead to an initial radiographic diagno-
sis of cavernous malformation. IMS are rare
and their behavior is unpredictable. Gross total
resection  is  the  goal  in  neurosurgical  treat-
ment  since  recurrence  and  malignancy  are
possibilities.
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Figure  8.  Spindled  cells,  numerous  late-
stage  melanosomes,  predominantly  stage
IV); surrounded by a characteristic single
continuous basal lamina.
Figure 9. A) Sagittal T1 magnetic resonance imaging without gadolinium contrast (post-
operative); B) sagittal T2 magnetic resonance imaging (post-operative).
A B
Table 1. Summary of reported cases.
#1 A 69 year old male with an IMS located between the caudal medulla and C3. Gross total
resection was achieved, but no follow-up was recorded.5
#2 A 72 year old female with an IMS located at C4-6. The lesion was partially resected and
the patient had a functional recovery.6
#3 A 63 year old female with an IMS located at C7-T1. A fine needle aspirate was
performed for diagnosis and no outcome was reported.7
#4 A 44 year old female with an IMS located at T2-T3. Gross total resection was achieved
and the patient partially recovered neurologically.8
#5 A 35 year old male with an IMS located at C4-C5.  Gross total resection was achieved
with a partial neurological recovery. The tumor recurred four years postoperatively
and was treated with surgery, radiation, and chemotherapy.2
#6 A 56 year old female with an IMS in the conus medullaris. Gross total resection was
achieved and the patient improved neurologically.9
#7 (current case) A 62 year old female with an IMS at T11.  Gross total resection was achieved and the
patient was functional with mild neurologic deficits at ten months post-operatively.
No recurrence was noted radiographically at ten months post-operatively.
Table 2. Presumed etiologies of intramedullary melanotic schwannoma.
1) Occasionally intramedullary spinal nerve fibers can occur, displacing Schwann cells centrally during 
embryogenesis.10,11
2) Perivascular bundles of peripheral nerves are a normal occurrence and have the potential to
displace Schwann cells intramedullary.8,12,13
3) Neoplastic extension of Schwann cells through the insertion site of the dorsal root.8,12,13
4) Neoplastic differentiation of neuroectodermal cells in the pia to form intramedullary melanotic
schwannoma.8,12
5) Disordered migration of neural crest cells during neural tube closure.6
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